Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk

Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk

(1) Background: The relationship between anxiety and depression in metabolic-dysfunction-associated fatty liver disease (MAFLD) and cardiovascular (CV) risk remains uncertain. Therefore, we aimed to assess whether anxiety and depression are associated with increased CV risk in MAFLD. (2) Methods: We...

Full description

Bibliographic Details
Main Authors: Abdulrahman Ismaiel, Mihail Spinu, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Bogdan Augustin Chis, Mihaela Fadgyas Stanculete, Dan Mircea Olinic, Dan L. Dumitrascu
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
metabolic-dysfunction-associated fatty liver disease (MAFLD)
hepatic steatosis
SteatoTest
anxiety
depression
Beck depression inventory
Online Access:https://www.mdpi.com/2077-0383/11/9/2488

Internet

https://www.mdpi.com/2077-0383/11/9/2488

Similar Items